Differential regulation of cathepsin S and cathepsin L in interferon γ-treated macrophages

Journal of Experimental Medicine

Volumn 197, Issue 2, 2003, Pages 169-179

  Beers, Courtney ^a   Honey, Karen ^a   Fink, Susan ^b   Forbush, Katherine ^a   Rudensky, Alexander ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cathepsin; IFN ; Ii processing; Macrophage; P41

Indexed keywords

CATHEPSIN L; CATHEPSIN S; CYTOKINE; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEINASE;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; IMMUNE RESPONSE; MACROPHAGE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CATHEPSINS; CYSTEINE ENDOPEPTIDASES; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERFERON-GAMMA, RECOMBINANT; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RNA, MESSENGER; TH1 CELLS;

EID: 0037454948     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20020978     Document Type: Article

References (45)

1. Cresswell, P. 1994. Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12:259-293.
2. Anderson, M.S., and J. Miller. 1992. Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA. 89:2282-2286.
3. Cresswell, P. 1996. Invariant chain structure and MHC class II function. Cell. 84:505-507.
4. Bakke, O., and B. Dobberstein. 1990. MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell. 63:707-716.
5. Lotteau, V., L. Teyton, A. Peleraux, T. Nilsson, L. Karlsson, S.L. Schmid, V. Quaranta, and P.A. Peterson. 1990. Intracellular transport of class II MHC molecules directed by invariant chain. Nature. 348:600-605.
6. Neefjes, J.J., and H.L. Ploegh. 1992. Intracellular transport of MHC class II molecules. Immunol. Today. 13:179-184.
7. Maric, M.A., M.D. Taylor, and J.S. Blum. 1994. Endosomal aspartic proteinases are required for invariant-chain processing. Proc. Natl. Acad. Sci. USA. 91:2171-2175.
8. Riese, R.J., P.R. Wolf, D. Bromme, L.R. Natkin, J.A. Villadangos, H.L. Ploegh, and H.A. Chapman. 1996. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity. 4:357-366.
9. Denzin, L.K., and P. Cresswell. 1995. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell. 82:155-165.
10. Martin, W.D., G.G. Hicks, S.K. Mendiratta, H.I. Leva, H.E. Ruley, and L. Van Kaer. 1996. H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell. 84:543-550.
11. Nakagawa, T., W. Roth, P. Wong, A. Nelson, A. Farr, J. Deussing, J.A. Villadangos, H. Ploegh, C. Peters, and A.Y. Rudensky. 1998. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science. 280:450-453.
12. Riese, K.J., K.N. Mitchell, J.A. Villadangos, G.P. Shi, J.T. Palmer, E.R. Karp, G.T. De Sanctis, H.L. Ploegh, and H.A. Chapman. 1998. Cathepsin S activity regulates antigen presentation and immunity. J. Clin. Invest. 101:2351-2363.
13. Nakagawa, T.Y., W.H. Brissette, P.D. Lira, R.J. Griffiths, N. Petrushova, J. Stock, J.D. McNeish, S.E. Eastman, E.D. Howard, S.R. Clarke, et al. 1999. Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity. 10:207-217.
14. Shi, G.P., J.A. Villadangos, G. Dranoff, C. Small, L. Gu, K.J. Haley, R. Piese, H.L. Ploegh, and H.A. Chapman. 1999. Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity. 10:197-206.
15. + T cell selection independently of its effect on invariant chain: a role in the generation of positively selecting peptide ligands. J. Exp. Med. 195:1349-1358.
16. Shi, G.P., R.A. Bryant, R. Riese, S. Verhelst, C. Driessen, Z. Li, D. Bromme, H.L. Ploegh, and H.A. Chapman. 2000. Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages. J. Exp. Med. 191:1177-1186.
17. Brocker, T., M. Riedinger, and K. Karjalainen. 1997. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J. Exp. Med. 185:541-550.
18. Honey, K., M. Duff, C. Beers, W.H. Brissette, E.A. Elliott, C. Peters, M. Maric, P. Cresswell, and A. Rudensky. 2001. Cathepsin S regulates the expression of cathepsin L and the turnover of gamma-interferon-inducible lysosomal thiol reductase in B lymphocytes. J. Biol. Chem. 276:22573-22578.
19. Bhattacharya, A., M.E. Dorf, and T.A. Springer. 1981. A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication. J. Immunol. 127:2488-2495.
20. Koch, N., S. Koch, and G.J. Hammerling. 1982. Ia invariant chain detected on lymphocyte surfaces by monoclonal antibody. Nature. 299:644-645.
21. Hume, D.A., and S. Gordon. 1983. Optimal conditions for proliferation of bone marrow-derived mouse macrophages in culture: the roles of CSF-1, serum, Ca2+, and adherence. J. Cell. Physiol. 117:189-194.
22. Guarneri, J.J. 1977. Influence of acute exposure to cigarette smoke on the alveolar macrophage system. J. Lab. Clin. Med. 89:1215-1224.
23. Karasuyama, H., and F. Melchers. 1988. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immunol. 18:97-104.
24. Mach, N., S. Gillessen, S.B. Wilson, C. Sheehan, M. Mihm, and G. Dranoff. 2000. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocytemacrophage colony-stimulating factor or Flt3-ligand. Cancer Res. 60:3239-3246.
25. Mason, R.W., D. Wilcox, P. Wikstrom, and E.N. Shaw. 1989. The identification of active forms of cysteine proteinases in Kirsten-virus-transformed mouse fibroblasts by use of a specific radiolabelled inhibitor. Biochem. J. 257:125-129.
26. Cao, H., R.G. Wolff, M.S. Meltzer, and R.M. Crawford. 1989. Differential regulation of class II MHC determinants on macrophages by IFN-gamma and IL-4. J. Immunol. 143:3524-3531.
27. Liuzzo, J.P., S.S. Petanceska, D. Moscatelli, and L.A. Devi. 1999. Inflammatory mediators regulate cathepsin S in macrophages and microglia: a role in attenuating heparan sulfate interactions. Mol. Med. 5:320-333.
28. Wang, Z., T. Zheng, Z. Zhu, R.J. Homer, R.J. Riese, H.A. Chapman, Jr., S.D. Shapiro, and J.A. Elias. 2000. Interferon gamma induction of pulmonary emphysema in the adult murine lung. J. Exp. Med. 192:1587-1600.
29. van's Gravesande, K.S., M.D. Layne, Q. Ye, L. Le, R.M. Baron, M.A. Perrella, L. Santambrogio, E.S. Silverman, and R.J. Riese. 2002. IFN regulatory factor-1 regulates IFNgamma-dependent cathepsin S expression. J. Immunol. 168:4488-4494.
30. Fiebiger, E., P. Meraner, E. Weber, I.F. Fang, G. Stingl, H. Ploegh, and D. Maurer. 2001. Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells. J. Exp. Med. 193:881-892.
31. Bevec, T., V. Stoka, G. Pungercic, I. Dolenc, and V. Turk. 1996. Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L.J. Exp. Med. 183:1331-1338.
32. Guncar, G., G. Pungercic, I. Klemencic, V. Turk, and D. Turk. 1999. Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S. EMBO J. 18:793-803.
33. Lennon-Dumenil, A.M., R.A. Roberts, K. Valentijn, C. Driessen, H.S. Overkleeft, A. Erickson, P.J. Peters, E. Bikoff, H.L. Ploegh, and P. Wolf Bryant. 2001. The p41 isoform of invariant chain is a chaperone for cathepsin L. EMBO J. 20:4055-4064.
34. Chapman, H.A., R.J. Riese, and G.P. Shi. 1997. Emerging roles for cysteine proteases in human biology. Annu. Rev. Physiol. 59:63-88.
35. Felbor, U., L. Dreier, R.A. Bryant, H.L. Ploegh, B.R. Olsen, and W. Mothes. 2000. Secreted cathepsin L generates endostatin from collagen XVIII. EMBO J. 19:1187-1194.
36. Villadangos, J.A., R.A. Bryant, J. Deussing, C. Driessen, A.M. Lennon-Dumenil, R.J. Riese, W. Roth, P. Saftig, G.P. Shi, H.A. Chapman, et al. 1999. Proteases involved in MHC class II antigen presentation. Immunol. Rev. 172:109-120.
37. Nakagawa, T.Y., and A.Y. Rudensky. 1999. The role of lysosomal proteinases in MHC class II-mediated antigen processing and presentation. Immunol. Rev. 172:121-129.
38. Hsieh, C.S., P. deRoos, K. Honey, C. Beers, and A.Y. Rudensky. 2002. A role for cathepsin L and cathepsin S in peptide generation for MHC class II presentation. J. Immunol. 168:2618-2625.
39. Pierre, P., and I. Mellman. 1998. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell. 93:1135-1145.
40. Cimerman, N., M.T. Prebanda, B. Turk, T. Popovic, I. Dolenc, and V. Turk. 1999. Interaction of cystatin C variants with papain and human cathepsins B, H and E.J. Enzyme Inhib. 14:167-174.
41. Fox, T., E. de Miguel, J.S. Mort, and A.C. Storer. 1992. Potent slow-binding inhibition of cathepsin B by its propeptide. Biochemistry. 31:12571-12576.
42. Carmona, E., E. Dufour, C. Plouge, S. Takebe, P. Mason, J.S. Mort, and R. Menard. 1996. Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases. Biochemistry. 35:8149-8157.
43. Guay, J., J.P. Falgueyret, A. Ducret, M.D. Percival, and J.A. Mancini. 2000. Potency and selectivity of inhibition of cathepsin K, L and S by their respective propeptides. Eur. J. Biochem. 267:6311-6318.
44. Ni, J., M.A. Fernandez, L. Danielsson, R.A. Chillakuru, J. Zhang, A. Grubb, J. Su, R. Gentz, and M. Abrahamson. 1998. Cystatin F is a glycosylated human low molecular weight cysteine proteinase inhibitor. J. Biol. Chem. 273:24797-24804.
45. Halfon, S., J. Ford, J. Foster, L. Dowling, L. Lucian, M. Sterling, Y. Xu, M. Weiss, M. Ikeda, D. Liggett, et al. 1998. Leukocystatin, a new Class II cystatin expressed selectively by hematopoietic cells. J. Biol. Chem. 273:16400-16408.